The “bacteria are rebelling… they’re turning the tide against antibiotics by outsmarting our wonder drugs,” that’s how the New York Times opens up its latest fearmongering article that, as usual, offers no real solution against the rise of drug resistant germs.
First of all, we don’t have any wonder drugs at all. Only toxic drugs are made available to sustain the “pharmakeia” sorcery. The decisive technology to suppress all drug resistant pathogens is persistently ignored, maligned, and suppressed in mainstream discussions.
The conflicting doubletalk is so glaring that they could not afford to laugh at their own stupidity. Some of the giveaways are these:
- Your children cannot go out publicly unless you are fully vaccinated, so you cannot infect the already “protected” vaccinated children in school, etc.
- They are helpless when it comes to dealing with “superbugs” at the same time that they are claiming that they are the “experts” in the field of medicine.
So, this is what the people are reading from the New York Times…
A Mysterious Infection, Spanning the Globe in a Climate of Secrecy
The rise of Candida auris embodies a serious and growing public health threat: drug-resistant germs.
Bacteria are rebelling. They’re turning the tide against antibiotics by outsmarting our wonder drugs. This video explores the surprising reasons.
Last May, an elderly man was admitted to the Brooklyn branch of Mount Sinai Hospital for abdominal surgery. A blood test revealed that he was infected with a newly discovered germ as deadly as it was mysterious. Doctors swiftly isolated him in the intensive care unit.
The germ, a fungus called Candida auris, preys on people with weakened immune systems, and it is quietly spreading across the globe. Over the last five years, it has hit a neonatal unit in Venezuela, swept through a hospital in Spain, forced a prestigious British medical center to shut down its intensive care unit, and taken root in India, Pakistan and South Africa.
The CDC is, of course, the Deep State agency assigned to force the mass vaccinations of children in order to weaken their autoimmune system and brain cells to mitigate future competition.
The man at Mount Sinai died after 90 days in the hospital, but C. auris did not. Tests showed it was everywhere in his room, so invasive that the hospital needed special cleaning equipment and had to rip out some of the ceiling and floor tiles to eradicate it.
“Everything was positive — the walls, the bed, the doors, the curtains, the phones, the sink, the whiteboard, the poles, the pump,” said Dr. Scott Lorin, the hospital’s president. “The mattress, the bed rails, the canister holes, the window shades, the ceiling, everything in the room was positive.”
auris is so tenacious, in part, because it is impervious to major antifungal medications, making it a new example of one of the world’s most intractable health threats: the rise of drug-resistant infections.
Dr. Shawn Lockhart, a fungal disease expert at the Centers for Disease Control and Prevention, holding a microscope slide with inactive Candida auris collected from an American patient.
For decades, public health experts have warned that the overuse of antibiotics was reducing the effectiveness of drugs that have lengthened life spans by curing bacterial infections once commonly fatal. But lately, there has been an explosion of resistant fungi as well, adding a new and frightening dimension to a phenomenon that is undermining a pillar of modern medicine.
“It’s an enormous problem,” said Matthew Fisher, a professor of fungal epidemiology at Imperial College London, who was a co-author of a recent scientific review on the rise of resistant fungi. “We depend on being able to treat those patients with antifungals.”
Simply put, fungi, just like bacteria, are evolving defenses to survive modern medicines.
Maybe their medicine is not modern enough. Or, maybe they’ve got the wrong expert. Maybe it’s time for them to call Dr. Tullio Simoncini instead, to teach them how to use baking soda solution against the growing fungal infection. But eliminating the problem is not the idea, of course.
Yet even as world health leaders have pleaded for more restraint in prescribing antimicrobial drugs to combat bacteria and fungi — convening the United Nations General Assembly in 2016 to manage an emerging crisis — gluttonous overuse of them in hospitals, clinics and farming has continued.
Well, the World Health Organization is also undermining antivaxxers’ independence from the use of heavy metal laden vaccines that have caused countless injuries, some of which have been successfully tried and compensated as per order of the court.
What is highly despicable, of course, is that the so-called experts and authorities in the field perpetually ignore the employment of real solutions to the problem.
Scientists say that unless more effective new medicines are developed and unnecessary use of antimicrobial drugs is sharply curbed, risk will spread to healthier populations. A study the British government funded projects that if policies are not put in place to slow the rise of drug resistance, 10 million people could die worldwide of all such infections in 2050, eclipsing the eight million expected to die that year from cancer.
Dr. Johanna Rhodes, an infectious disease expert at Imperial College London. “We are driving this with the use of antifungicides on crops,” she said of drug-resistant germs. Credit: Tom Jamieson for The New York Times
The solution is to depart from the protocols formulated by vested interest groups and enterprise, and consider a totally different approach. Or, risk being part of the statistics.
In the United States, two million people contract resistant infections annually, and 23,000 die from them, according to the official C.D.C. estimate. That number was based on 2010 figures; more recent estimates from researchers at Washington University School of Medicine put the death toll at 162,000. Worldwide fatalities from resistant infections are estimated at 700,000.
It’s still your choice.